Gefitinib vs Montelukast

Gefitinib vs Montelukast: Overview

This comparison examines the pharmacological differences between Gefitinib and Montelukast.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Montelukast — 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Montelukast — C35H36ClNO3S.

Molecular Weight: Gefitinib — 446.9000 g/mol; Montelukast — 586.1800 g/mol.

Type: Gefitinib — Small molecule; Montelukast — Small molecule.